- Home
- USCB vs DRTS Comparison
USCB vs DRTS Comparison
Compare USCB & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USCB
- DRTS
- Stock Information
- Founded
- USCB 2002
- DRTS 2015
- Country
- USCB United States
- DRTS Israel
- Employees
- USCB N/A
- DRTS N/A
- Industry
- USCB Major Banks
- DRTS Medical/Dental Instruments
- Sector
- USCB Finance
- DRTS Health Care
- Exchange
- USCB Nasdaq
- DRTS Nasdaq
- Market Cap
- USCB 316.4M
- DRTS 300.2M
- IPO Year
- USCB 2021
- DRTS N/A
- Fundamental
- Price
- USCB $17.36
- DRTS $3.81
- Analyst Decision
- USCB Strong Buy
- DRTS Strong Buy
- Analyst Count
- USCB 3
- DRTS 1
- Target Price
- USCB $22.00
- DRTS $9.00
- AVG Volume (30 Days)
- USCB 20.0K
- DRTS 63.6K
- Earning Date
- USCB 10-30-2025
- DRTS 08-11-2025
- Dividend Yield
- USCB 2.31%
- DRTS N/A
- EPS Growth
- USCB 67.08
- DRTS N/A
- EPS
- USCB 1.47
- DRTS N/A
- Revenue
- USCB $88,094,000.00
- DRTS N/A
- Revenue This Year
- USCB $26.38
- DRTS N/A
- Revenue Next Year
- USCB $4.39
- DRTS N/A
- P/E Ratio
- USCB $11.78
- DRTS N/A
- Revenue Growth
- USCB 32.06
- DRTS N/A
- 52 Week Low
- USCB $13.90
- DRTS $2.11
- 52 Week High
- USCB $21.86
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- USCB 52.23
- DRTS 66.03
- Support Level
- USCB $16.75
- DRTS $3.51
- Resistance Level
- USCB $17.50
- DRTS $3.99
- Average True Range (ATR)
- USCB 0.53
- DRTS 0.18
- MACD
- USCB 0.00
- DRTS 0.04
- Stochastic Oscillator
- USCB 37.65
- DRTS 80.00
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.